Foundations of Healthcare Material and Equipment Management

Introduction and Context

Healthcare cannot be delivered safely, continuously, or economically without the right materials and equipment being available at the right place, time, quantity, quality, and cost. A surgical procedure depends not only on clinical expertise but also on sterile instruments, implants, medicines, protective equipment, functioning monitors, reliable utilities, information systems, and trained personnel. Failure in any of these supporting elements may delay treatment, increase clinical risk, waste resources, or damage public trust.

Healthcare material and equipment management is therefore much more than purchasing and storing supplies. It is an integrated managerial discipline concerned with planning, sourcing, receiving, inspecting, storing, distributing, using, maintaining, tracking, and disposing of resources required for patient care. It connects clinical priorities with finance, logistics, engineering, quality management, infection prevention, regulatory compliance, and sustainability.

At postgraduate level, the subject should be understood as a systems discipline. A low purchase price may generate high lifetime cost if equipment is unreliable. Excess inventory may appear to improve availability but can conceal obsolete stock, consume working capital, and increase expiry-related losses. Conversely, aggressive cost reduction can create stock-outs or encourage the use of unsuitable substitutes. Sound management balances availability, quality, safety, lifecycle cost, resilience, and ethical responsibility.

Learning Objectives

By the end of this chapter, the learner should be able to:

1. Define the scope and terminology of healthcare material and equipment management.
2. Distinguish consumables, drugs, implants, capital equipment, and support assets.
3. Explain how materials and equipment influence clinical quality, patient safety, cost control, and operations.
4. Identify the major stakeholders and describe their competing interests.
5. Apply a lifecycle perspective to healthcare resources.
6. Analyse common governance, ethical, technological, and operational challenges.
7. Use appropriate managerial principles in an applied healthcare case.

1. Scope and Meaning of the Discipline

Material management traditionally refers to the planning and control of materials from the point at which a need is identified until the material is consumed or discarded. In healthcare, this scope is broadened because resources may be sterile, temperature-sensitive, regulated, implanted into the body, connected to patients, or essential to life support.

Equipment management concerns assets that support diagnosis, treatment, monitoring, rehabilitation, administration, and facility operations. It includes selection, specification, procurement, installation, acceptance testing, training, preventive maintenance, calibration, repair, cybersecurity where applicable, decommissioning, and replacement planning.

The integrated term healthcare material and equipment management includes five connected activities:

• Need determination: translating service demand and clinical pathways into resource requirements.
• Resource acquisition: selecting suppliers and obtaining suitable products or services.
• Logistics and control: receiving, storing, issuing, tracking, and replenishing resources.
• Lifecycle support: maintaining equipment, managing warranties, training users, and monitoring performance.
• End-of-life governance: preventing unsafe use, managing recalls, disposing of waste, and replacing assets responsibly.

The discipline operates at strategic, tactical, and operational levels. Strategic decisions include standardisation, outsourcing, supplier relationships, technology investment, and resilience. Tactical decisions include forecasting, inventory policies, contract management, and maintenance planning. Operational decisions include requisitioning, stock rotation, equipment checks, and responding to urgent shortages.

2. Essential Terminology

Several terms are used inconsistently across healthcare organisations. Clear definitions are essential for accountability and data quality.

A distinction should also be made between availability and accessibility. An item may exist in a central store but not be accessible to a clinical unit at the required time. Similarly, apparent availability may be misleading if an item is expired, damaged, incompatible, or unavailable because trained users are absent.

3. Classification of Healthcare Resources

Classification supports budgeting, forecasting, storage design, procurement controls, and risk management. Categories may overlap; for example, a drug can be a consumable in financial planning but a regulated product in legal and clinical governance.

3.1 Consumables

Consumables are items normally used once or for a short period and then discarded, depleted, or rendered unsuitable for reuse. Examples include syringes, gloves, dressings, sutures, specimen containers, disinfectants, and laboratory reagents.

Their management challenges include variable demand, wide product variety, unit-of-measure confusion, expiry, contamination risk, and the need for rapid replenishment. Some low-cost consumables are operationally critical. A missing blood-collection tube or sterile catheter can delay a high-value clinical service.

Consumables should be classified by clinical criticality, not merely by price. A practical classification may include routine, essential, emergency-critical, sterile, temperature-sensitive, hazardous, and controlled items.

3.2 Drugs and Pharmaceutical Products

Medicines require specialised controls because their identity, strength, formulation, storage conditions, expiry, and administration directly affect patient outcomes. Management includes formulary decisions, demand forecasting, batch and expiry tracking, cold-chain control, controlled-drug security, medication safety, and recall response.

The principle of first-expiry, first-out is generally preferable for dated products, although local procedures must account for product integrity and legal requirements. Substitution decisions must be clinically authorised; purchasing staff should not independently replace a prescribed or approved product with an apparently similar item.

3.3 Implants and High-Risk Clinical Products

Implants include orthopaedic joints, cardiac devices, vascular grafts, intraocular lenses, and other products intended to remain in or interact closely with the body. They require exceptionally strong traceability because a device may need to be linked to a patient, procedure, clinician, lot, serial number, and supplier.

Implant management involves clinical selection, informed consent, sterile handling, inventory visibility, consignment controls, documentation, surveillance of adverse events, and recall capability. The economic value of an implant is less important than its clinical suitability and long-term risk profile.

3.4 Capital Equipment

Capital equipment is durable equipment acquired for repeated use over an extended period. Examples include magnetic resonance imaging systems, operating tables, ventilators, ultrasound systems, sterilizers, laboratory analysers, and patient-monitoring systems.

Capital decisions should consider more than purchase price. Relevant issues include clinical capacity, interoperability, facility requirements, workforce competence, consumable dependence, maintenance support, software licensing, cybersecurity, downtime, energy use, resale or disposal, and replacement timing.

3.5 Support Assets and Infrastructure

Support assets enable care without necessarily touching the patient. They include generators, medical-gas systems, water-treatment equipment, refrigeration, sterilization infrastructure, transport vehicles, information technology, laundry equipment, waste systems, and storage facilities.

These assets are frequently overlooked because their contribution is indirect. A generator failure may compromise theatres and intensive care; a malfunctioning refrigerator may damage vaccines; inadequate storage may compromise sterile supplies. Support assets should therefore be included in risk registers and continuity plans.

4. Objectives of Healthcare Material and Equipment Management

The central objective is to ensure that safe and suitable resources are available when needed while minimising avoidable total cost and waste. This objective has several dimensions.

Availability and Continuity

Clinical services depend on uninterrupted access. Availability requires demand estimation, appropriate safety stock, reliable suppliers, alternative sourcing, and escalation procedures. It does not justify indiscriminate accumulation of stock. The desired state is controlled availability: sufficient protection against uncertainty without excessive inventory.

Quality and Fitness for Purpose

A product must meet its intended clinical and technical requirements. Quality includes identity, performance, sterility, packaging, compatibility, durability, and regulatory status. A cheaper product that fails under clinical conditions is not economical.

Patient Safety

Management systems should prevent wrong-item selection, expired-product use, device malfunction, inadequate maintenance, and incomplete traceability. Safety is strengthened by standardisation, labelling, segregation of high-risk products, user training, incident reporting, and learning from near misses.

Cost Control and Value

Cost control is not simply price reduction. It involves reducing waste, unnecessary variation, emergency purchases, excess stock, avoidable downtime, inefficient utilisation, and premature replacement. Value is better considered as the relationship between outcomes achieved and resources consumed.

A useful conceptual expression is:

This is a management concept rather than a universal accounting formula. “Outcomes” must be defined for the decision, such as safe procedures completed, diagnostic accuracy, patient recovery, or service availability. Total resources may include purchase, labour, maintenance, infrastructure, training, and disposal costs. The expression should not be used to compare services unless outcomes and cost boundaries are measured consistently.

Operational Efficiency

Efficient management reduces searching, waiting, duplicate ordering, unnecessary movement, avoidable repairs, and administrative work. It supports timely patient flow and allows clinical staff to spend more time on care rather than locating supplies or compensating for unreliable equipment.

Compliance and Accountability

Healthcare resources are subject to procurement rules, professional standards, device and medicines regulation, occupational safety, infection prevention, environmental law, and financial controls. Documentation should show who specified, approved, purchased, received, issued, maintained, used, and retired an item.

Sustainability and Resilience

Sustainable management considers energy consumption, packaging, waste, reusability where safe, ethical sourcing, supplier labour practices, and disposal impacts. Resilience concerns the ability to absorb disruptions such as pandemics, transport failures, cyberattacks, geopolitical events, or supplier insolvency.

5. Stakeholders and Governance

Material and equipment decisions involve stakeholders with different priorities. Clinical users prioritise safety and performance; finance seeks affordability and budget discipline; procurement seeks competition and procedural compliance; biomedical engineering focuses on technical reliability; infection prevention focuses on contamination control; pharmacy focuses on medicine safety; patients expect effective and ethical care; suppliers seek commercial sustainability.

A governance structure should reconcile these interests through transparent roles and evidence-based decisions. Common mechanisms include a materials management committee, pharmacy and therapeutics committee, medical device committee, capital investment committee, infection prevention committee, and technology assessment process. Their mandates should be coordinated rather than isolated.

Stakeholder participation is especially important during specification. If procurement writes specifications without clinicians, the item may be technically compliant but clinically unsuitable. If clinicians choose equipment without finance or engineering input, hidden lifecycle costs and infrastructure constraints may be missed.

A robust decision record normally includes:

• the clinical or operational problem;
• alternatives considered;
• technical and user requirements;
• safety and regulatory checks;
• lifecycle cost and budget impact;
• supplier and supply-risk assessment;
• training, maintenance, and infrastructure requirements;
• implementation and evaluation measures; and
• conflict-of-interest declarations.

Ethical governance requires fairness, transparency, proportionality, and avoidance of improper supplier influence. Gifts, sponsorships, preferential access, and undisclosed relationships can compromise decisions even when no explicit rule is broken. Patient interests should remain the primary reference point.

6. The Resource Lifecycle

A lifecycle model prevents organisations from treating procurement as the end of management. The stages are interdependent:

1. Assessment of need: Identify service demand, clinical risk, existing capacity, and alternatives.
2. Specification: Define performance, quality, compatibility, safety, regulatory, and user requirements without unnecessarily restricting competition.
3. Appraisal and selection: Compare clinical benefit, total cost, supplier capability, risk, and sustainability.
4. Procurement and contracting: Establish price, delivery, warranties, service levels, training, data obligations, and remedies.
5. Receipt and acceptance: Verify quantity, condition, documentation, conformity, and performance before use.
6. Storage and distribution: Maintain security, environmental conditions, traceability, and stock rotation.
7. Use and monitoring: Ensure correct use, user competence, incident reporting, and performance review.
8. Maintenance and support: Conduct preventive maintenance, calibration, repairs, software updates, and spare-parts management.
9. Review and replacement: Evaluate utilisation, failure history, obsolescence, clinical appropriateness, and future demand.
10. Decommissioning and disposal: Remove unsafe assets, protect confidential data, manage hazardous waste, and document final disposition.

For equipment, a simplified total-cost model may be written as:

where TCO is total cost of ownership; P is purchase price; I is installation and infrastructure cost; Tr is training cost; M is maintenance and repair cost; E is operating cost such as energy and consumables; D is decommissioning and disposal cost; and R is residual value or recoverable return. All terms must be measured over the same defined period and in comparable monetary units. The model is a managerial approximation: it may omit difficult-to-monetise effects such as clinical risk, downtime, or staff satisfaction.

7. Inventory and Equipment Control Principles

Inventory control seeks a balance between service protection and resource efficiency. Important practices include accurate item masters, standard units of measure, authorised stock locations, cycle counting, segregation of quarantined or recalled products, expiry monitoring, and documented adjustments.

A basic replenishment policy often uses a reorder point. Under relatively stable demand, a conceptual form is:

where ROP is reorder point in units, d is average demand per time unit, L is lead time in the same time unit, and SS is safety stock in units. The equation assumes that demand and lead time are represented adequately by averages and that the item is replenished through a reasonably predictable process. It does not by itself determine an appropriate service level or safety stock; those require analysis of variability, criticality, and the consequences of shortage.

For example, if a ward uses 12 catheter packs per day, supplier lead time is 5 days, and approved safety stock is 20 packs, then:

When inventory position reaches approximately 80 packs, replenishment should be initiated, subject to local policy and open orders. This is not a guarantee against stock-out if demand suddenly increases or delivery fails.

Equipment control requires an asset register containing, as appropriate, asset identification, location, custodian, manufacturer, model, serial number, acquisition date, warranty, risk classification, maintenance schedule, calibration status, software version, and retirement decision. Equipment that is physically present but absent from the register is effectively unmanaged.

8. Clinical Quality, Patient Safety, and Cost Relationships

The relationship between management and clinical outcomes is causal but often indirect. Poor specification may lead to incompatible devices. Inadequate storage may compromise sterility. Missed preventive maintenance may produce inaccurate measurements. Unclear labelling may result in selection errors. Delayed procurement may force emergency purchasing at higher cost and increase clinical disruption.

Quality improvement should therefore connect material data with clinical data. Examples include relating stock-outs to cancelled procedures, device failures to adverse events, reagent shortages to delayed diagnoses, and maintenance compliance to equipment downtime.

Important indicators may include:

• stock-out frequency and duration;
• emergency purchase rate;
• inventory accuracy;
• expiry and obsolescence losses;
• order-fill rate;
• supplier on-time and in-full performance;
• preventive-maintenance completion;
• equipment availability and downtime;
• calibration compliance;
• recall closure time; and
• cost per procedure or episode, where measurement boundaries are clear.

Indicators should be interpreted cautiously. A high inventory turnover may reflect efficiency or dangerous understocking. High equipment utilisation may indicate productivity or excessive workload and inadequate backup. Metrics should be triangulated with safety events, user feedback, and service outcomes.

9. Technology and Contemporary Developments

Digital systems can improve visibility, but technology is not a substitute for sound processes. Barcodes and radio-frequency identification can support receiving, issuing, patient-level traceability, and inventory accuracy. Enterprise resource planning systems integrate purchasing, finance, stores, and asset records. Computerised maintenance systems schedule work orders and preserve service history.

Artificial intelligence may assist demand forecasting, anomaly detection, predictive maintenance, product substitution analysis, and supplier-risk monitoring. However, AI outputs depend on data quality and may reproduce historical bias. It should support—not silently replace—professional judgement, especially where decisions affect patient safety. Governance should address explainability, validation, cybersecurity, privacy, human oversight, and accountability for errors.

Connected medical equipment creates additional cybersecurity and interoperability obligations. A device may require secure software updates, access control, network segmentation, incident response, and coordination between clinical engineering and information security. Disposal of digital equipment must also include secure erasure of patient and organisational data.

Contemporary supply chains emphasise resilience through dual sourcing, regional capacity, critical-item mapping, supplier financial assessment, emergency stock policies, and scenario planning. Resilience should be risk-based: not every item requires duplicate suppliers or large reserves, but items with severe clinical consequences and limited alternatives deserve stronger protection.

10. Illustrative Case: Managing a Critical Infusion-Pump Fleet

Background

A 350-bed hospital experienced repeated delays in administering intravenous therapy. The hospital owned 420 infusion pumps, but clinical units reported that pumps were frequently unavailable or faulty. Procurement records showed recent purchases, yet the asset register listed only 310 pumps.

Problem

An initial review identified four linked problems. First, equipment was moved between wards without location updates. Second, models from several manufacturers required different tubing and programming procedures. Third, preventive maintenance was overdue for many pumps. Fourth, purchasing focused on acquisition price and did not include the cost of proprietary consumables, batteries, software support, and staff training.

Analysis

The hospital formed a multidisciplinary team involving nursing, pharmacy, biomedical engineering, procurement, infection prevention, finance, and risk management. It reconciled the physical count with the asset register, quarantined damaged pumps, reviewed incident reports, and mapped demand by ward. The analysis showed that apparent ownership did not equal usable capacity. Of 420 physical pumps, 34 were under repair, 22 lacked current electrical safety checks, 18 had missing accessories, and 27 were incompatible with the tubing stocked in particular wards.

The team estimated usable capacity, assessed peak demand, and identified the clinical consequences of pump shortages. It also reviewed total cost per pump family rather than comparing purchase prices alone.

Approach and Solution

The hospital adopted a five-part plan:

1. Create a single controlled pump standard for new purchases unless a documented clinical exception existed.
2. Establish a complete asset register with barcode identification and ward-level accountability.
3. Introduce acceptance testing, preventive-maintenance scheduling, and quarantine procedures.
4. Standardise compatible tubing and provide competency-based user training.
5. Contract for parts, software support, response times, and end-of-life planning using lifecycle-cost criteria.

A dashboard tracked usable-pump availability, maintenance compliance, missing assets, incident reports, and cancelled or delayed treatments. Nurses were given a simple reporting route for faults, while biomedical engineering received authority to remove unsafe equipment immediately.

Outcome

After implementation, the hospital reported improved visibility of pump location, fewer incompatible-accessory incidents, and reduced emergency rentals. The most important improvement was not simply a larger equipment count; it was an increase in clinically usable, traceable, and supported capacity. The hospital also recognised that standardisation must remain responsive to genuine clinical requirements rather than becoming an inflexible purchasing rule.

Learning Points

The case demonstrates that equipment availability is a system property. It depends on physical possession, working condition, accessories, software, user competence, maintenance, location control, and clinical suitability. It also illustrates why the lowest purchase price can be a misleading measure of value and why equipment management belongs jointly to clinical, technical, financial, and operational leadership.

11. Challenges and Limitations

Healthcare organisations face persistent uncertainty. Demand may change rapidly because of outbreaks, seasonal illness, demographic shifts, or new clinical practice. Suppliers may experience shortages, recalls, transport disruption, or financial failure. Product proliferation can increase complexity and reduce purchasing leverage.

Data quality is another limitation. Inaccurate consumption records, inconsistent item descriptions, unrecorded transfers, and incomplete maintenance histories undermine forecasting and performance measurement. A sophisticated dashboard built on unreliable data can create false confidence.

Standardisation also has limits. Excessive variation increases cost and training burden, but excessive standardisation may suppress innovation or fail to accommodate specialist patient needs. Decisions should distinguish unnecessary variation from clinically justified diversity.

Finally, cost-effectiveness evidence may be incomplete. Benefits such as avoided harm, staff confidence, resilience, and equity are difficult to express in monetary terms. Managers should make assumptions explicit and use sensitivity analysis or scenario comparison when uncertainty is material.

Best-Practice Principles

1. Link resource decisions to clinical pathways and patient risk.
2. Classify items by criticality, not only by price.
3. Use lifecycle cost rather than acquisition price alone.
4. Maintain accurate item, supplier, inventory, and asset data.
5. Involve clinical, technical, financial, infection-prevention, and patient-safety stakeholders.
6. Build traceability for medicines, implants, devices, and recalled products.
7. Treat maintenance, training, accessories, and infrastructure as part of the purchase decision.
8. Monitor both efficiency and safety outcomes.
9. Use technology with human oversight and strong cybersecurity.
10. Prepare continuity plans for critical resources and review them through realistic scenarios.

Chapter Summary

Healthcare material and equipment management is an integrated discipline that ensures safe, suitable, and economical resources support patient care. Its scope extends from need assessment and specification through procurement, storage, use, maintenance, traceability, replacement, and disposal. Consumables, drugs, implants, capital equipment, and support assets have different risk profiles and therefore require different controls.

The discipline contributes to clinical quality by ensuring fitness for purpose, to patient safety through maintenance and traceability, to cost control through lifecycle analysis and waste reduction, and to operational continuity through forecasting and resilience. Effective governance aligns clinicians, procurement, finance, engineering, pharmacy, infection prevention, patients, and suppliers. Technology can improve visibility and prediction, but it cannot compensate for weak data, unclear accountability, or poor process design. The central managerial principle is to pursue value and safe continuity rather than price minimisation alone.

Key Terms

Material: A physical item used in care or support operations.

Consumable: An item depleted, discarded, or rendered unsuitable after short-term use.

Drug: A regulated pharmaceutical product used to prevent, diagnose, treat, or manage disease.

Implant: A medical product intended to remain in or interact closely with the body.

Capital equipment: A durable asset expected to provide service over several years.

Support asset: Infrastructure or equipment that enables healthcare operations indirectly.

Inventory: Stock held for future use.

Stock-out: Unavailability of a required item when needed.

Lead time: Time from order placement to acceptable receipt.

Traceability: Ability to track an item’s identity, movement, history, or use.

Standardisation: Deliberate reduction of unnecessary product or model variation.

Preventive maintenance: Planned work intended to preserve performance and reduce failure.

Corrective maintenance: Work performed to restore equipment after failure.

Calibration: Comparison or adjustment against a reference standard to maintain measurement accuracy.

Total cost of ownership: Acquisition, operating, maintenance, support, and disposal costs across an asset’s life.

Recall: Formal corrective action or removal of a product because of a safety or quality concern.

Resilience: Capacity to prepare for, absorb, and recover from disruption.

Lifecycle management: Coordinated management from need identification through disposal.

Review Questions

Short Answer Questions

1. Define healthcare material and equipment management.
2. State two differences between consumables and capital equipment.
3. Why is traceability particularly important for implants?
4. What is meant by total cost of ownership?
5. Identify four stakeholders involved in equipment decisions.

Long Answer Questions

1. Explain how material and equipment management influences clinical quality, patient safety, and operational continuity.
2. Compare the management requirements of consumables, drugs, implants, capital equipment, and support assets.
3. Discuss why acquisition price alone is an inadequate basis for capital-equipment decisions.
4. Describe the stages of the healthcare resource lifecycle and explain the managerial purpose of each stage.
5. Evaluate the role of governance, standardisation, and stakeholder participation in healthcare procurement.

Analytical / Application Questions

1. A hospital frequently experiences stock-outs of low-cost sterile supplies while holding large quantities of rarely used items. Analyse the likely causes and propose an improvement plan.
2. A diagnostic analyser has a low purchase price but requires proprietary reagents, specialist training, and frequent service visits. Develop a framework for deciding whether it represents good value.
3. Following a device recall, patient-level records are incomplete and several devices cannot be located. Analyse the safety and governance implications and design a corrective action programme.

Multiple Choice Questions with Answers

Question 1

Which statement best describes the scope of healthcare material and equipment management?

A. It is limited to purchasing and receiving supplies.

B. It integrates planning, acquisition, logistics, use, maintenance, and disposal of healthcare resources.

C. It concerns only high-value medical devices.

D. It is primarily an accounting process for reducing expenditure.

Correct Answer: B. It integrates planning, acquisition, logistics, use, maintenance, and disposal of healthcare resources.

Question 2

Which item is most clearly a consumable?

A. Magnetic resonance imaging system

B. Hospital generator

C. Sterile syringe used for one procedure

D. Operating-room building

Correct Answer: C. Sterile syringe used for one procedure

Question 3

Why do implants require especially strong traceability?

A. They are always the least expensive clinical products.

B. They must be linked to patients, procedures, lots, or serial numbers for safety and recall purposes.

C. They do not require clinical authorisation.

D. They are normally stored without packaging.

Correct Answer: B. They must be linked to patients, procedures, lots, or serial numbers for safety and recall purposes.

Question 4

What is the principal limitation of using purchase price alone to compare equipment?

A. Purchase price is never recorded in financial systems.

B. It ignores operating, maintenance, training, infrastructure, and disposal costs.

C. It always overestimates equipment value.

D. It applies only to consumables.

Correct Answer: B. It ignores operating, maintenance, training, infrastructure, and disposal costs.

Question 5

A unit uses 12 packs per day, lead time is 5 days, and safety stock is 20 packs. Using ROP = dL + SS, what is the reorder point?

A. 60 packs

B. 72 packs

C. 80 packs

D. 100 packs

Correct Answer: C. 80 packs

Question 6

Which activity is an example of preventive maintenance?

A. Repairing a monitor after it fails

B. Replacing a component during a scheduled service before failure occurs

C. Discarding an expired dressing

D. Ordering an additional product after a stock-out

Correct Answer: B. Replacing a component during a scheduled service before failure occurs

Question 7

Which stakeholder is primarily responsible for technical reliability and maintenance assessment of medical equipment?

A. Biomedical engineering

B. Patient registration

C. Catering services

D. Public relations

Correct Answer: A. Biomedical engineering

Question 8

What is the main purpose of a controlled asset register?

A. To record only the purchase price of equipment

B. To identify, locate, monitor, maintain, and govern equipment throughout its life

C. To replace all clinical training

D. To eliminate the need for user reporting

Correct Answer: B. To identify, locate, monitor, maintain, and govern equipment throughout its life

Question 9

Which practice best supports medicine inventory safety?

A. Using products with the nearest expiry last

B. Mixing quarantined and usable stock

C. Maintaining batch and expiry tracking with appropriate stock rotation

D. Allowing unauthorised substitutions by purchasing staff

Correct Answer: C. Maintaining batch and expiry tracking with appropriate stock rotation

Question 10

Which statement best expresses a sound approach to standardisation?

A. All products must be identical regardless of clinical need.

B. Variation should be reduced when unnecessary, while justified clinical differences are retained.

C. Standardisation is relevant only to finance departments.

D. Standardisation eliminates the need for maintenance.

Correct Answer: B. Variation should be reduced when unnecessary, while justified clinical differences are retained.